Search

Author/Creator Fang, Bruno

1. Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021). Issue 7 (July 2022)

Authors:
Agarwal, Neeraj; McGregor, Bradley; Maughan, Benjamin L; Dorff, Tanya B; Kelly, William; Fang, Bruno; McKay, Rana R; Singh, Parminder; Pagliaro, Lance; Dreicer, Robert; Srinivas, Sandy; Loriot, Yohann; Vaishampayan, Ulka; Goel, Sanjay; Curran, Dominic; Panneerselvam, Ashok; Schwickart, Martin; Ch...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 7(2022)
Page Start:
899
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search